Evidence map›Paper›PMID 19416894›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Many different Vbeta CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions.

Kira Rubtsova, James P Scott-Browne, Frances Crawford, Shaodong Dai, Philippa Marrack, John W Kappler

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Class II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptors.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. T-cell receptor (TCR) interaction with peptides that mimic nickel offers insight into nickel contact allergy.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  16. Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kira RubtsovaHoward Hughes Medical Institute and Integrated Department of Immunology, National Jewish Health, Denver, CO 80206, USA.
James P Scott-Browne
Frances Crawford
Shaodong Dai
Philippa Marrack
John W Kappler
Howard Hughes Medical Institute · USNational Jewish Health · USUniversity of Colorado Denver · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
REGULATORY MECHANISMS IN THE IMMUNE SYSTEMR01AI017134 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 1985 to 2006
$1.6M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Regulatory Mechanisms in the Immune SystemR56AI017134 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 2007 to 2007
$321k
REGULATORY MECHANISMS IN THE IMMUNE SYSTEMR37AI017134 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 1987 to 1996
–
Howard Hughes Medical InstituteNIAID NIH HHS AI-07405NIAID NIH HHS AI-17134NIAID NIH HHS AI-18785NIAID NIH HHS AI-22295NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI017134NIAID NIH HHS R01 AI018785NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI017134NIAID NIH HHS R56 AI018785NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

We have hypothesized that in the prenegative selection TCR repertoire, many somatically generated complementary-determining region (CDR) 3 loops combine with evolutionarily selected germline Valpha/Vbeta CDR1/CDR2 loops to create highly MHC/peptide cross-reactive T cells that are subsequently deleted by negative selection. Here, we present a mutational analysis of the Vbeta CDR3 of such a cross-reactive T-cell receptor (TCR), YAe62. Most YAe62 TCRs with the mutant CDR3s became less MHC promiscuous. However, others with CDR3s unrelated in sequence to the original recognized even more MHC alleles than the original TCR. Most importantly, this recognition was still dependent on the conserved CDR1/CDR2 residues. These results bolster the idea that germline TCR V elements are inherently reactive to MHC but that this reactivity is fine-tuned by the somatically generated CDR3 loops.

Indexed as

AllelesAnimalsComplementarity Determining RegionsDNA Mutational AnalysisFlow CytometryGene DeletionGerm-Line MutationInterleukin-2LigandsMajor Histocompatibility ComplexMiceMice, Inbred NODMolecular ConformationPeptidesReceptors, Antigen, T-CellComplementarity Determining RegionsInterleukin-2LigandsPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID19416894
PMCPMC2674405
OpenAlexW2158344454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.